Literature DB >> 4944072

Effects of globus pallidus lesions and Parkinson's disease on brain glutamic acid decarboxylase.

P L McGeer, E G McGeer, J A Wada, E Jung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4944072     DOI： 10.1016/0006-8993(71)90334-9

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  10 in total

1.  The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.

Authors:  Richard B Silverman
Journal:  J Med Chem       Date:  2012-01-10       Impact factor: 7.446

2.  Release of endogenous GABA from the substantia nigra is not controlled by GABA autoreceptors.

Authors:  P C Waldmeier; P Wicki; J J Feldtrauer; P A Baumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

3.  Caudate stimulation and substantia nigra activity in the rat.

Authors:  A Dray; T J Gonye; N R Oakley
Journal:  J Physiol       Date:  1976-08       Impact factor: 5.182

Review 4.  Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.

Authors:  K Gale; M Casu
Journal:  Mol Cell Biochem       Date:  1981-09-25       Impact factor: 3.396

5.  Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors.

Authors:  Hejun Lu; Richard B Silverman
Journal:  J Med Chem       Date:  2006-12-14       Impact factor: 7.446

6.  Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings].

Authors:  A L Jaton; D M Loew; J M Vigouret
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

7.  d-Amphetamine-induced depression of central dopamine neurons: evidence for mediation by both autoreceptors and a striato-nigral feedback pathway.

Authors:  B S Bunney; G K Aghajanian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

8.  Effects of drugs and axotomy on acetylcholine levels in central cholinergic neurons.

Authors:  H Rommelspacher; M J Kuhar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

9.  Alteration of basal ganglia evoked responses by reserpine and L-dopa.

Authors:  W C Koller; C A Berry
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

10.  Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities.

Authors:  S Mithani; S Atmadja; K G Baimbridge; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.